Search - tctmd.com

Displaying 201 - 220 of 224

Sort: Relevancy | Date

Presentation TCT 2013

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Presenter: Patrick Serruys

October 27, 2013

Presentation TCT 2013

Latest Results from ABSORB Extend: Comparison with Xience

Presenter: Bernard Chevalier

October 27, 2013

Presentation TCT 2013

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Presenter: Peter Smits

October 27, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives II

Presenter: Robert-Jan van Geuns

October 27, 2013

Presentation TCT 2013

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Presenter: Gregg Stone

October 27, 2013

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Conference News TCT 2012

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

October 24, 2012

Presentation TCT 2012

TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND...

Presenter: Takashi Muramatsu

October 23, 2012

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program

Presenter: Gregg Stone

October 23, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

Presenter: Nienke van Ditzhuijzen, Oana Sorop, Mieke van den Heuvel, Jurgen M.R. Ligthart, Karen T. Witberg, Richard van Duin, Ilona Krabbendam-Peters, Douglas Follett, Nagarajan Ramesh, Richard Rapoza, Dirk J. Duncker, Evelyn Regar, Heleen M.M. van Beusekom, Hector M. Garcia-Garcia, Wim J. van der Giessen

January 03, 2012

Presentation TCT 2012

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Presenter: John Ormiston, William Wijns, Charlene Knape, Mathias Vrolix, James Stewart, Mark Webster, Robert Whitbourn, Alexandra Lansky, Hiram Bezzera, Peter Fitzgerald, David Kandzari

January 03, 2012

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Conference News

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

November 10, 2011

News Conference News

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

November 08, 2011

Video

» Interview

TCT 2018: Dr. C. Michael Gibson talks with Dr. Gregg Stone about ABSORB IV

September 24, 2018

Video

» Interview

TCT 2018: Dr. C. Michael Gibson talks with Dr. Pieter Smits about COMPARE ABSORB

September 24, 2018

Advertisement

Lessons from Multimodality Imaging from ABSORB Cohort A (5 Years) and Cohort B (3 Years)

Latest Results from ABSORB Extend: Comparison with Xience

It's Not a Metallic DES! Procedural Tips and Tricks to Optimizing ABSORB Outcomes

Is ABSORB a Workhorse DES? Real-world Perspectives II

Demonstration of Clinical Superiority with a Bioresorbable Vascular Scaffold: The ABSORB IV Clinical Trial

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

TCT-40. Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND...

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program

ABSORB (Abbott Vascular) Program to Date: Integrated Insights from Multimodality Imaging

ABSORB (Abbott Vascular) Clinical Program to Date (and EXTEND Results): Strengths, Limitations, Including the 6-month Unknowns of the ABSORB Stent

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

EVOLVE: Bioabsorbable EES Noninferior to Permanent Polymer Version

Bioabsorbable Polymers, Scaffolds Offer Permanent Advantages

TCT 2018: Dr. C. Michael Gibson talks with Dr. Gregg Stone about ABSORB IV

TCT 2018: Dr. C. Michael Gibson talks with Dr. Pieter Smits about COMPARE ABSORB

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content